1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow SHR7390: new trials by email Literature Review of SHR7390 trials Research Report on SHR7390
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer SHR7390 - Metastatic Castration-resistant Prostate Cancer | Phase 2 | Completed | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 6 | 2020-12-17 | 2023-06-13 |
| Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer SHR7390, Famitinib, SHR3162 - Breast Cancer, Metastatic Cancer | Phase 2 | Unknown | Fudan University | 319 | 2020-05-01 | 2022-07-26 |
Breast Neoplasms (1) · Neoplasm Metastasis (1)
Fudan University (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)
China (2)
Hongqian Guo (1) · Zhi-Ming Shao (1)